Savaria Corp header image

Savaria Corp

SIS

Equity

ISIN null / Valor 1385257

Toronto Stock Exchange (2026-02-24)
CAD 25.66-0.35%

Savaria Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Savaria Corporation is a global leader in the accessibility industry, specializing in the design, manufacturing, and distribution of a wide range of mobility products. The company's extensive product portfolio includes home elevators, commercial lifts, stairlifts, ceiling lifts, and adapted vehicles, catering to individuals with mobility challenges. Additionally, through its Span division, Savaria offers medical beds and therapeutic surfaces. With manufacturing facilities strategically located in North America, Europe, and China, Savaria is well-positioned to serve global markets and customize solutions to meet specific customer needs. The company has expanded its reach through strategic acquisitions, such as the purchase of Handicare AB, enhancing its presence in the European and Far East markets. Savaria's leadership team, including executives like Jean-Philippe DeMontigny and Clare Brophy, brings extensive experience in growth strategies and market expansion, further solidifying its position in the accessibility sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

43.0%1Y
55.9%3Y
40.0%5Y

Performance

24.3%1Y
24.4%3Y
27.4%5Y

Volatility

Market cap

1341 M

Market cap (USD)

Daily traded volume (Shares)

87,216

Daily traded volume (Shares)

1 day high/low

20.08 / 19.87

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 129508879
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.08%DKK 243.65
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.19%USD 16.12
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 119.17
TAL Education Group
TAL Education Group TAL Education Group Valor: 11869921
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.40%USD 10.96
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.44%USD 4.54
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.67%EUR 14.96
Sandoz Group Ltd
Sandoz Group Ltd Sandoz Group Ltd Valor: 124359842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%CHF 65.64
dentalcorp Holdings Ltd
dentalcorp Holdings Ltd dentalcorp Holdings Ltd Valor: 111405816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.09%CAD 11.00
PharmaSGP Holding SE
PharmaSGP Holding SE PharmaSGP Holding SE Valor: 55294050
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.13%EUR 33.00
Soleno Therapeutics Inc
Soleno Therapeutics Inc Soleno Therapeutics Inc Valor: 121339545
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.24%USD 39.16